The Valley Desk

NCT07134088 · Interventional trial

A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov